2021–2022 EU CLOs: Collateral Breakdown by Industry

Please find the table below for the CLO collateral exposure by industry (Moody’s classification) based on EU CLO deals closed in 2021–2022. The median EU CLO deal has an 15.8% exposure to Healthcare & Pharmaceuticals.

This content is for Freemium members only.
Login Join Now